中生制药(01177.HK)药物获国家药监局仿制药质量和疗效一致性评价
中生制药(01177.HK)公布,抗感染药物「头孢(口夫)辛酯片」已获得中国国家药监局颁发药品补充申请批准通知书,通过了仿制药质量和疗效一致性评价。
头孢(口夫)辛酯片属於第二代头孢菌素类药物,其临床应用广泛,适用於对该品种敏感的病原菌所致的感染,常用於中重度的下呼吸道感染如急慢性支气管炎、肺炎,还用於泌尿系感染如肾盂肾炎、复杂性尿路感染以及腹腔感染如腹膜炎、胆道感染等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.